Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. nightwatch

NIGHTWATCH SIGNED

NightWatch - Clinically-proven detection and alert system for critical nocturnal epileptic seizures.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 NIGHTWATCH project word cloud

Explore the words cloud of the NIGHTWATCH project. It provides you a very rough idea of what is the project "NIGHTWATCH" about.

prevents    preferred    monitor    relief    social    19m    reduces    reducing    company    despite    sudden    90    false    heavy    caregivers    minimize    wearables    dutch    tele    few    pushing    rate    urgent    leads    flagship    anxiety    societal    33    algorithm    prevented    seek    detect    commercial    30    patients    worldwide    sleep    ai    wards    more    movement    remote    people    nightwatch    lack    time    heart    device    intramural    care    clinically    trend    40    28    peace    accumulated    attending    self    2013    die    patterns    patient    north    critical    severe    life    46    registered    unexpected    2019    conceived    notifies    caused    mind    market    quality    nocturnal    america    institutes    seizures    sudep    continuous    bracelet    gt    followed    detects    wirelessly    improves    medication    home    uses    types    suffer    billion    profit    medical    spin    tested    independency    automatically    deaths    roi    created    epilepsy    full    giving    off    adapting    uncontrolled    50m    seizure    alarm    livassured    seconds    depression    specialised    combination    least    4    death    professionals    monitoring   

Project "NIGHTWATCH" data sheet

The following table provides information about the project.

Coordinator		 LIVASSURED BV 

Organization address
address: ALBERTUSSTRAAT 34
city: VUGHT
postcode: 5261AD
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Netherlands [NL]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-12-01   to  2020-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    LIVASSURED BV NL (VUGHT) coordinator 50˙000.00

Map

 Project objective

More than 50M people worldwide suffer from epilepsy, characterized by uncontrolled seizures, and about 30% find no relief from those despite taking medication. Nocturnal seizures can be critical; each year at least 33.000 people in EU die of Sudden Unexpected Death in Epilepsy (SUDEP), 40% of which could be prevented by attending the seizures on time. This is a continuous challenge for patients and caregivers, with important social and societal consequences (anxiety, depression, lack of sleep), and high intramural care costs (over €20 billion per year in EU). The NightWatch is a registered medical device that detects and notifies wirelessly remote caregivers in case of heavy nocturnal seizures in just few seconds. The bracelet uses a combination of heart rate and movement measurement, a unique AI algorithm conceived by three Dutch institutes specialised in epilepsy, automatically adapting to different patient patterns to minimize false alarm rate. It has been clinically tested and can detect > 90% of all types of urgent nocturnal seizures making it the most reliable system available. The NightWatch targets caregivers, patients and professionals who seek an effective alarm system for severe nocturnal seizures. It improves their quality of life giving them peace of mind, higher level of independency, reduces cost of care by reducing the need for intramural attention, and prevents deaths caused by SUDEP. With a trend to-wards home care and self-monitoring pushing market growth (expected to reach €4.0 billion in 2019), wearables becoming the preferred type of seizure monitoring. EU leads the seizure monitor devices market (46%), followed by North America (28%). NightWatch is the flagship product of LivAssured, a Dutch company created in 2013 as a spin-off to take over the commercial exploitation of the research results of the Tele-Epilepsy Consortium on nocturnal seizures. With its full commercial exploitation, we expect an accumulated profit of €19M and a ROI of 4

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "NIGHTWATCH" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "NIGHTWATCH" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Colourganisms (2020)

Microbial production of custom-made, pure and sustainable anthocyanins

Read More  

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More  

VINOQUANT11SUPERPLUS (2019)

A digital based system for measuring, showing and regulation of the complexe system of wine feremtation with high precision via a Bluetooth -Refractometer, a Software and a Bluetooth Thermostat

Read More